About 8,840,000 results
Open links in new tab
US FDA approves GSK’s AREXVY, the world’s first respiratory …
GSK Announces Positive Topline Data on Co-Administration of AREXVY …
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
US FDA approves expanded age indication for GSK’s AREXVY, the …
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
US FDA approves GSK’s Arexvy, the world’s first respiratory …
New data for AREXVY, GSK’s RSV vaccine, show potential to help …
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK shares positive data for AREXVY, its respiratory syncytial virus ...
About Arexvy (respiratory syncytial virus vaccine, adjuvanted) - GSK